Survival prediction in patients treated by FOLFIRI and bevacizumab for metastatic colorectal cancer (PRODIGE 9) using contrast-enhanced CT texture analysis (SPECTRA)
ANNÉE
2017
AUTEURS
Dohan A, Gallix B, Guiu B, Le Malicot K, Reinhold C, Soyer P, Bennouna J, Ghiringhelli F, Boige V, Taieb J, Bouche O, Francois E, Phelip JM, Borel C, Faroux R, Seitz JF, Jacquot S, Lepage C, Aparicio T, Hoeffe C
CONGRÈS/REVUE
ASCO
ÉTUDE
Localisation
LIEN PUBLICATIONS ASSOCIÉES